» Articles » PMID: 35820905

MST4 Negatively Regulates Type I Interferons Production Via Targeting MAVS-mediated Pathway

Overview
Publisher Biomed Central
Date 2022 Jul 12
PMID 35820905
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Cytosolic RNA sensing can elicit immune responses against viral pathogens. However, antiviral responses must be tightly regulated to avoid the uncontrolled production of type I interferons (IFN) that might have deleterious effects on the host. Upon bacterial infection, the germinal center kinase MST4 can directly phosphorylate the adaptor TRAF6 to limit the inflammatory responses, thereby avoiding the damage caused by excessive immune activation. However, the molecular mechanism of how MST4 regulates virus-mediated type I IFN production remains unknown.

Methods: The expression levels of IFN-β, IFIT1, and IFIT2 mRNA were determined by RT-PCR. The expression levels of p-IRF3, IRF3, RIG-I, MAVS, and MST4 proteins were determined by Western blot. The effect of secreted level of IFN-β was measured by ELISA. The relationship between MST4 and MAVS was investigated by immunofluorescence staining and coimmunoprecipitation.

Results: In this study, we reported that MST4 can act as a negative regulator of type I IFN production. Ectopic expression of MST4 suppressed the Poly (I:C) (polyino-sinic-polycytidylic acid)- and Sendai virus (SeV)-triggered production of type I IFN, while the knockdown of MST4 enhanced the production of type I IFN. Mechanistically, upon SeV infection, the MST4 competed with TRAF3 to bind to the 360-540 domain of MAVS, thereby inhibiting the TRAF3/MAVS association. Additionally, MST4 facilitated the interaction between the E3 ubiquitin ligase Smurf1 and MAVS. This promoted the K48-linked ubiquitination of MAVS, thereby accelerating the ubiquitin-mediated proteasome degradation of MAVS.

Conclusions: Our findings showed that MST4 acted as a crucial negative regulator of RLR-mediated type I IFN production. Video Abstract.

Citing Articles

Targeting STK26 and ATG4B: miR-22-3p as a modulator of autophagy and tumor progression in HCC.

Li K, Bai Y, Wang J, Ren L, Mo A, Liu R Transl Oncol. 2024; 51:102214.

PMID: 39608212 PMC: 11635773. DOI: 10.1016/j.tranon.2024.102214.


CC Chemokine 2 Promotes Ovarian Cancer Progression through the MEK/ERK/MAP3K19 Signaling Pathway.

Liu W, Wang L, Zhang J, Cheng K, Zheng W, Ma Z Int J Mol Sci. 2023; 24(13).

PMID: 37445830 PMC: 10341728. DOI: 10.3390/ijms241310652.


Uncovering new insights into the role of the ubiquitin ligase Smurf1 on the regulation of innate immune signaling and resistance to infection.

Souza-Costa L, Andrade-Chaves J, Andrade J, Costa V, Franco L Front Immunol. 2023; 14:1185741.

PMID: 37228615 PMC: 10203584. DOI: 10.3389/fimmu.2023.1185741.

References
1.
Xiang Y, Zhang W, Jia P, Lu X, Liu W, Yi M . E3 Ubiquitin Ligase RNF114 Inhibits Innate Immune Response to Red-Spotted Grouper Nervous Necrosis Virus Infection in Sea Perch by Targeting MAVS and TRAF3 to Mediate Their Degradation. J Immunol. 2020; 206(1):77-88. DOI: 10.4049/jimmunol.2000083. View

2.
Jiao S, Zhang Z, Li C, Huang M, Shi Z, Wang Y . The kinase MST4 limits inflammatory responses through direct phosphorylation of the adaptor TRAF6. Nat Immunol. 2015; 16(3):246-57. DOI: 10.1038/ni.3097. View

3.
Pasrija R, Naime M . The deregulated immune reaction and cytokines release storm (CRS) in COVID-19 disease. Int Immunopharmacol. 2020; 90:107225. PMC: 7691139. DOI: 10.1016/j.intimp.2020.107225. View

4.
Saha S, Pietras E, He J, Kang J, Liu S, Oganesyan G . Regulation of antiviral responses by a direct and specific interaction between TRAF3 and Cardif. EMBO J. 2006; 25(14):3257-63. PMC: 1523175. DOI: 10.1038/sj.emboj.7601220. View

5.
Lukhele S, Boukhaled G, Brooks D . Type I interferon signaling, regulation and gene stimulation in chronic virus infection. Semin Immunol. 2019; 43:101277. PMC: 8029807. DOI: 10.1016/j.smim.2019.05.001. View